HR 6482 · 116th Congress · Health

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Introduced 2020-04-10· Sponsored by Rep. Gallagher, Mike [R-WI-8]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Oversight and Investigations.(2020-07-13)

Plain Language Summary

[AI summary unavailable — showing source text] Protecting Our Pharmaceutical Supply Chain from China Act of 2020 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (11)

11 Republicans
Rep. Cheney, Liz [R-WY-At Large]WY
Rep. Stefanik, Elise M. [R-NY-21]NY
Rep. Budd, Ted [R-NC-13]NC
Rep. Van Drew, Jefferson [R-NJ-2]NJ
Rep. Hartzler, Vicky [R-MO-4]MO
Rep. Posey, Bill [R-FL-8]FL
Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]PR
Rep. Biggs, Andy [R-AZ-5]AZ
Rep. Lesko, Debbie [R-AZ-8]AZ
Rep. Baird, James R. [R-IN-4]IN
Rep. Turner, Michael R. [R-OH-10]OH